Moderna’s COVID-19 vaccine has received full FDA approval for use in children at higher risk for severe illness.

Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 3.6% in the morning session after JPMorgan added the stock to its ...

The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

The mRNA technology behind the Pfizer and Moderna vaccines are groundbreaking, but their potential goes way beyond COVID-19.

The average short interest for the S&P 500 Health Care Index Sector (NYSEARCA:XLV) experienced an increase in June, moving ...

Dear J.H.: Metformin, a treatment for diabetes that works mostly by preventing the liver from making sugar, isn't new and has ...

The annual football game at Sportsman's Park in the 1930s drew big crowds ...

Welcome to Fierce Pharma's regulatory tracker for the second half of 2025. | In this tracker, Fierce Pharma is recording the ...

Scientists comment on reports that a child has died in a Liverpool hospital after contracting measles. Prof Sir Andrew Pollard FRCPCH FMedSci FRS, Director of the Oxford Vaccine Group, and Ashall ...

As vaccination rates among children continue to plummet, concerns are rising over the potential for infectious disease to spread rampantly.

Screening of more than 12,000 Aspergillus fumigatus isolates collected from Dutch hospitals found 15% harbored triazole ...

Pennsylvania first detected CWD in 2012 in Adams County, and the disease has since spread to all south-central counties, ...